InvestorsHub Logo
Followers 25
Posts 1336
Boards Moderated 0
Alias Born 11/15/2016

Re: Hercules1 post# 47699

Thursday, 02/09/2017 10:44:44 PM

Thursday, February 09, 2017 10:44:44 PM

Post# of 203912
This is why I think we will hear about our multiple myeloma testing moving to orphan drug testing soon. Read about one of our latest 8-k regarding Ms. Sani. She is well experienced with getting FDA approval!

Ms. Sani is the CEO and owner of "Shefa Amirim" Ltd, which provides regulatory affairs and clinical consultation services for early-stage start-ups in various medical fields. Shefa Amirim provides clients with the requisite regulatory plans, designing and conducting the required clinical studies, CRO services and the preparation of technical files and related services necessary for FDA applications and approval. During the past five years, Ms. Sani has shepherded various projects and treatments in the areas of dermatology, proctology, cardio-vascular, ophthalmology, urology, cell therapy, OBYOGN and IVD's through both regulatory affairs and clinical studies.